Novartis Access® offers a portfolio of on- and off-patent medicines addressing key noncommunicable diseases (NCDs): cardiovascular diseases, type 2 diabetes, respiratory illnesses and breast cancer.

The Novartis Access portfolio is offered as a basket to governments, NGOs and other institutional customers in lower-income countries at a price of USD 1 per treatment per month. Depending on public subsidy levels, patients in participating countries may either receive Novartis Access medicines free of charge or purchase them at a low price to manage their chronic condition long-term. For those who need to purchase their treatments, we are working with our partners to minimize markups.

Learn more about Novartis Access